TY  - JOUR 
AU  - Carrato, Alfredo
AU  - Abad, Albert
AU  - Massuti, Bartomeu
AU  - Grávalos, Cristina
AU  - Escudero, Pilar
AU  - Longo-Muñoz, Federico
AU  - Manzano, José-Luis
AU  - Gómez, Auxiliadora
AU  - Safont, María José
AU  - Gallego, Javier
AU  - García-Paredes, Beatriz
AU  - Pericay, Carles
AU  - Dueñas, Rosario
AU  - Rivera, Fernando
AU  - Losa, Ferrán
AU  - Valladares Ayerbes, Manuel
AU  - González, E
AU  - Aranda, E
AU  - Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
PY  - 2017
UR  - http://hdl.handle.net/20.500.11940/9542
AB  - In first-line wild-type (WT)-Kirsten rat sarcoma viral oncogene homologue (KRAS) metastatic colorectal cancer (mCRC), panitumumab (Pmab) improves outcomes when added to FOLFOX [folinic acid, 5-fluorouracil, and oxaliplatin] or FOLFIRI [folinic acid,...
LA  - eng
KW  - Appetite
KW  - Skin
KW  - Neutropenia
KW  - Fluorouracil
KW  - Leucovorin
KW  - Pruritus
KW  - Asthenia
KW  - Medical Oncology
KW  - Colorectal Neoplasms
TI  - First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD).
DO  - 10.1016/j.ejca.2017.04.024
T2  - European journal of cancer (Oxford, England : 1990)
M2  - 191
KW  - Panitumumab
KW  - FOLFOX
KW  - Cáncer colorrectal metastásico
VL  - 81
ER  -